From theheart.org, by Sue Hughes Johannesburg, South Africa – A novel agent that reduces LDL production by inhibiting apolipoprotein B (apoB) synthesis could be an effective therapy for patients with severe hypercholesterolemia, a new study suggests [1]. The...
Recent Comments